Expansion and partnerships Cannabotech's recent partnership with NXTLVL for manufacturing oncology products in California indicates a focus on expanding its product reach and potentially tapping into a new market segment. Exploring further collaboration opportunities with similar organizations could lead to additional sales channels.

Innovative product development The introduction of the My Being App by Cannabotech, which integrates DNA testing and real-time specialist contact, showcases innovation in healthcare technology. Leveraging such advanced tools to enhance customer experience and personalized healthcare solutions can attract tech-savvy clientele and drive sales growth.

Cancer-focused solutions Cannabotech's ongoing development of cancer-targeted formulas for various cancer types demonstrates a specialized focus on addressing specific medical needs. Identifying healthcare facilities or clinics specializing in cancer treatment and promoting the benefits of Cannabotech's products could capture a niche market and boost sales.

Financial milestone Cannabotech's successful public equity offering and substantial funding of $8 million indicate financial stability and investor confidence in the company's growth prospects. Utilizing this funding to upscale marketing efforts and product research could position the company for increased sales volumes and market visibility.

Acquisition benefits The acquisition of Tikunolam's assets by Cannabotech for $41.5 million presents an opportunity for market expansion and diversification. Leveraging acquired assets to strengthen product portfolios and entering new market territories based on Tikunolam's operations could lead to business growth and enhanced sales performance.